Crinetics Pharmaceuticals CRNX Free cash flow yield
Free cash flow yield at other companies
Other financials
Where this comes from
Calculated from Crinetics Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The official record: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Crinetics Pharmaceuticals's free cash flow yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Crinetics Pharmaceuticals's free cash flow yield?
- Crinetics Pharmaceuticals (CRNX) reported free cash flow yield of -11% in Q1 2026.
- How has Crinetics Pharmaceuticals's free cash flow yield changed year-over-year?
- Crinetics Pharmaceuticals's free cash flow yield decreased by 27.7% year-over-year, from -8.6% to -11%.
- What is the long-term trend for Crinetics Pharmaceuticals's free cash flow yield?
- Over 5 years (2020 to 2025), Crinetics Pharmaceuticals's free cash flow yield has grown at a -1.3% compound annual growth rate (CAGR), from -9.3% to -8.7%.
- What does free cash flow yield mean?
- Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.